Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers
By: David R. Gandara, MD
Current Issues in Checkpoint Immunotherapy for NSCLC: A Perspective from February 2020
By: David R. Gandara, MD
Session I - Screening Prevention Early-Stage Lung Cancer
By: David T. Cooke, MD, Ken Yoneda, MD, Heather Wakelee, MD, Johannes Kratz, MD, PhD, Megan Daly, MD
EGFR: Common and Uncommon Mutations and What Is Next for This Patient Population
By: Edgardo S Santos, MD, FACP
